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Objectives This study sought to determine whether procedural factors during percutaneous coro-
nary intervention (PCI) are associated with the occurrence of ischemic stroke or transient ischemic
attack (PCI-stroke).
Background Stroke is a devastating complication of PCI. Demographic predictors are nonmodiﬁable.
Whether PCI-stroke is associated with procedural factors, which may be modiﬁable, is unknown.
Methods We performed a single-center retrospective study of 21,497 PCI hospitalizations between
1994 and 2008. We compared procedural factors from patients who suffered an ischemic stroke or
transient ischemic attack related to PCI (n  79) and a control group (n  158), and matched them
2:1 based on a predicted probability of stroke developed from a logistic regression model.
Results PCI-stroke procedures involved the use of more catheters (median: 3 [quarter (Q) 1, Q3:
3, 4] vs. 3 [Q1, Q3: 2, 3], p  0.001), greater contrast volumes (250 ml vs. 218 ml, p  0.006),
and larger guide caliber (median: 7-F [Q1, Q3: 6, 8] vs. 6-F [Q1, Q3: 6, 8], p  0.001). The num-
ber of lesions attempted (1.7  0.8 vs. 1.5  0.8, p  0.14) and stents placed (1.4  1.2 vs. 1.2  1.1,
p  0.35) were similar between groups, but PCI-stroke patients were more likely to have undergone
rotational atherectomy (10% vs. 3%, p  0.029). Overall procedural success was lower in the PCI-
stroke group compared with controls (71% vs. 85%, p  0.017). Evaluation of the entire PCI popula-
tion revealed no difference in the rate of PCI-stroke between radial and femoral approaches (0.4%
vs. 0.4%, p  0.78).
Conclusions Ischemic stroke related to PCI is associated with potentially modiﬁable technical pa-
rameters. Careful procedural planning is warranted, particularly in patients at increased risk.
(J Am Coll Cardiol Intv 2012;5:200–6) © 2012 by the American College of Cardiology
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201Stroke is an infrequent but potentially devastating compli-
cation of percutaneous coronary intervention (PCI). It is
associated with an in-hospital mortality rate of 20% (1–4),
and in survivors of the initial event, with markedly increased
long-term mortality (1). Moreover, for the patient, the
possible occurrence of a major stroke may be perceived as
being an outcome worse than death (2).
PCI-related mortality and adverse events other than
stroke have progressively declined over the last 2 decades
(3–5). However, the incidence of PCI stroke has remained
unchanged at approximately 0.3% to 0.4% (1,6–8). Independent
redictors include age, female sex, renal failure, and prior
istory of stroke or transient ischemic attack (TIA) (1,6–8).
ith the worsening demographic risk profile of patients
eing referred for PCI, and increasing procedural complex-
ty (1), it seems unlikely that the incidence of stroke related
o PCI will decline in the near future.
Approximately 90% of symptomatic strokes or TIAs
elated to PCI are ischemic (PCI-stroke [1,4]). The poten-
ial mechanisms underlying these events include emboliza-
ion of atheroma from the aortic wall due to catheter-related
rauma, embolization of thrombus or air, dissection from
atheter or guidewire manipulation, and periprocedural
ypotension (9–11). In support of the hypothesis of debris
islodgement during catheterization, transcranial Doppler
ignals have been shown to increase during passage of
atheters around the aortic arch, suggestive of microembo-
ization (12). Studies assessing the risk of catheter-related
mboli report a significantly higher embolic event rate in
atients with atherosclerosis compared to those without
therosclerosis (13). Furthermore, analysis of 1,000 consec-
tive guiding catheters removed after PCI revealed the
resence of macroscopic aortic debris within the guide
umen in more than 50% of cases (14).
Whether there is a relationship between procedural
actors that might influence the extent of embolization
nd the occurrence of PCI-stroke remains unknown.
iven the devastating nature of the complication, and the
nability to affect demographic risk factors, it is critically
mportant to identify those variables that could poten-
ially be modifiable in an attempt to reduce the risk of
rocedural stroke. In this retrospective, single-center
tudy, our objective was to identify procedural factors in
atients undergoing PCI who experienced an ischemic
eurologic complication compared with a matched con-
rol population of those who did not.
ethods
Patient population. Patients undergoing PCI at the Mayo
Clinic in Rochester, Minnesota, are prospectively followed
in a registry that includes demographic, clinical, angio-
graphic, and procedural data. Immediate and in-hospital
events are recorded, and each patient is surveyed by tele-phone using a standardized questionnaire at 6 months, 1
year, and then annually after the procedure. Ten percent of
all records are randomly audited by the supervisor for data
integrity. All adverse events are confirmed by reviewing the
medical records of the patients followed at our institution
and by contacting the patients’ physicians and reviewing the
hospital records of patients followed elsewhere.
All PCIs from January 1, 1994, to March 31, 2008, were
eligible for analysis. For patients with multiple PCIs during
a single hospitalization, only the first PCI was included.
Patients who did not consent to use of their records for
research were excluded as per Minnesota state statute.
There were 22,038 PCI hospitalizations of 17,689 unique
patients during this period. Of those, 440 patients refused
authorization of their records for research and were ex-
cluded, leaving 21,497 hospitalizations for analysis.
Seventy-nine patients experiencing an in-hospital ischemic
stroke or TIA relating to PCI were identified, and their
demographic and angiographic variables were compared
with the entire remaining nonstroke population as controls.
Next, detailed medical record
and angiographic review was
performed to identify procedural
variables from the PCI-stroke
patients, which were compared
with procedural variables from
158 matched control patients.
Deﬁnitions. Ischemic stroke was
defined as nonhemorrhagic stroke
or TIA related to PCI in the ab-
sence of other causes. All patients
suffering ischemic stroke after PCI
were evaluated by a consultant neu-
rologist. Brain imaging (computed
tomography, magnetic resonance imaging, or both) excluded
hemorrhage in all patients. Where there was uncertainty as to
the relationship between the PCI procedure and neurologic
event, adjudication was performed by an independent consul-
tant neurologist.
The number of diseased coronary arteries was defined by
the number of major arteries with at least 50% stenosis,
provided at least 1 of the major arteries had at least 70%
stenosis. Patients with 50% stenosis in the left main
coronary artery were considered to have 2-vessel disease if
there was right dominance and 3-vessel disease if there was
left dominance. Myocardial infarction was diagnosed in the
presence of at least 2 of 3 criteria: 1) typical chest pain for
at least 20 min; 2) elevation of serum creatine kinase levels
(or the myocardial band fraction) 2 times normal; and
3) a new Q-wave on the electrocardiogram. Severe renal
dysfunction was defined as a creatinine level of 3.0 mg/dl
or a history of dialysis or renal transplant. Cardiogenic shock
was defined as a prolonged systolic arterial pressure95 mm Hg,
Abbreviations
and Acronyms
LV  left ventricular
PCI  percutaneous
coronary intervention
PCI-stroke  ischemic
stroke or transient ischemic
attack related to
percutaneous coronary
intervention
TIA  transient ischemic
attackor systolic arterial pressure 110 mm Hg while on ino-
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202tropes or with intra-aortic balloon pump support. Proce-
dural success was defined as a reduction of residual luminal
diameter stenosis to 20% without in-hospital death,
Q-wave myocardial infarction, or need for emergency cor-
onary artery bypass graft. Prior history of stroke or TIA was
defined as a documented history of stroke or TIA that
resulted in abnormalities in vision, speech, sensation, or
motor function or a history of cerebrovascular (carotid)
surgery. Congestive heart failure was defined as any docu-
mentation of congestive cardiac failure in the medical
record.
Matching and statistical analysis. Continuous variables are
summarized as mean  SD (unless otherwise noted) and
categorical variables as frequency (percentage). In the overall
PCI population, differences between patients with and
without stroke were calculated via logistic models with
generalized estimating equations to account for the corre-
lation between multiple PCIs on the same patient. Patients
without stroke were matched to ischemic stroke patients at
a 2:1 matching ratio. Matching was based on the logit of the
predicted probability of stroke from a logistic regression
model, including age, sex, body mass index, unstable angina,
pre-PCI myocardial infarction, pre-PCI shock, congestive
heart failure at presentation, hypertension, history of pe-
ripheral vascular disease, history of stroke or TIA, diabetes,
chronic renal disease, ejection fraction 40%, number of
diseased vessels, presence of thrombus, multivessel interven-
tion. Control subjects must have had their PCI within 2
years of their matched stroke patient, and the propensity
score had to be within one-quarter of the sample standard
deviation. Conditional logistic regression was used to com-
pare clinical, angiographic, and procedural variables be-
tween stroke patients and the matched controls.
Results
Baseline clinical characteristics. ISCHEMIC STROKE VERSUS ALL NON-
STROKE PATIENTS. Between 1994 and 2008, the incidence of
PCI-related ischemic neurologic events was 0.37%. Patients
who experienced PCI-stroke (n 79; comprising 60 strokes
and 19 TIAs) compared with nonstroke control subjects
(n  21,418) were more likely to be older (age 75  10
years vs. 66  12 years, p  0.001); women (51% vs. 29%,
 0.001); have a prior history of stroke or TIA (35% vs.
1%, p  0.001); have a history of peripheral vascular
isease (19% vs. 11%, p  0.034), congestive heart failure
(24% vs. 15%, p  0.046), or cardiogenic shock before the
procedure (11% vs. 4%, p  0.001); or have suffered
myocardial infarction within 7 days of PCI (59% vs.
32%, p  0.001) (Table 1). Further analysis revealed older
patients with a prior neurologic history to be a high-risk
subgroup for developing ischemic stroke related to PCI.
Specifically, in patients aged 70 to 79 years with a prior
history of stroke or TIA, the risk of PCI-stroke was 1.4% inmen and 1.6% in women. In those over 80 years, the risk
rose further to 1.6% in men and 3% in women.
ISCHEMIC STROKE VERSUS MATCHED CONTROLS. Based on the preceding
predictors, a logistic regression model was constructed,
allowing the calculation of a logit of probability of PCI-
stroke for patients undergoing PCI from 1994 to 2008.
Matching was performed using this logit and identified 2
control patients, with similar baseline probability of isch-
emic PCI-stroke but who did not suffer an event, for each
PCI-stroke patient studied. After matching, there were no
major differences in demographic characteristics between
patients who experienced ischemic PCI-stroke and their
control subjects (Table 2). The presence of hypercholester-
olemia was found to be statistically greater in the ischemic
stroke group than in the control group, but this variable was
not found to be a significant predictor in logistic regression
analysis. Additionally, there was no significant difference in
pre-procedural cardiac medication profile, including anti-
platelet and heparin usage between groups, although there
were trends toward less angiotensin-converting enzyme
inhibitor and more thrombolysis usage in the PCI-stroke
population (Table 3).
Angiographic characteristics. Baseline angiographic charac-
teristics were compared between the stroke patients and
their matched control subjects. Most angiographic param-
Table 1. Patient Characteristics: Ischemic Stroke Versus
Nonstroke Control Subjects
PCI-Stroke
(n  79)
Control Subjects
(n  21,418) p Value
Age, yrs 74.9 10.0 66.3 12.0 0.001
Male 39 (49) 15,141 (71) 0.001
Body mass index, kg/m2 28.5 5.1 29.5 5.6 0.13
Unstable angina 40 (51) 12,867 (60) 0.089
MI within 7 days prior 46 (59) 6,824 (32) 0.001
History of MI, 7 days 19 (24) 6,813 (32) 0.14
Pre-procedural shock 9 (11) 816 (4) 0.001
CHF status 0.046
Never 55 (76) 17,318 (85)
Previous 4 (6) 917 (4)
Current 13 (18) 2,235 (11)
History of cholesterol 240, mg/dl 56 (80) 14,714 (75) 0.38
Peripheral vascular disease 15 (19) 2,393 (11) 0.034
History of CVA or TIA 26 (35) 2,415 (11) 0.001
Diabetes 24 (31) 5,339 (25) 0.25
Moderate-to-severe renal disease 6 (8) 800 (4) 0.081
Tumor/lymphoma/leukemia 10 (13) 2,514 (12) 0.82
Metastatic cancer 1 (1) 188 (1) 0.72
EF 40% 13 (16) 2,126 (10) 0.056
Values are mean SD or n (%).
CHF congestive heart failure; CVA cerebrovascular accident; EF ejection fraction;
MImyocardial infarction; PCI-stroke ischemic stroke or transient ischemic attack related to
percutaneous coronary intervention; TIA transient ischemic attack.eters were similar in both groups (Table 4). Consequent to
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203matching, procedural urgency, the number of diseased vessels,
and the presence of intracoronary thrombus were equally
represented in the 2 groups. Unmatched parameters, including
number of lesions treated and frequency of vein graft interven-
tions, were not statistically different between the groups.
Overall procedural success was lower in the PCI-stroke group
than with control subjects, driven by higher rates of in-hospital
death (18% vs. 8%, p 0.043), requirement for coronary artery
ypass graft (5% vs. 0%, p 0.003), and residual stenosis after
CI (18% vs. 10%, p  0.09).
Procedural characteristics. Features of the procedure itself
were compared between patients who suffered a PCI-related
ischemic stroke and matched control subjects, and these are
outlined in Table 5. Ischemic stroke was associated with
rotational atherectomy, urgent intra-aortic balloon pump
usage, higher contrast volumes, total number of diagnostic
and guiding catheters passed, and with caliber of guiding
catheter used. Moreover, larger caliber guide catheters
Table 2. Patient Characteristics: Ischemic Stroke Versus
Matched Controls
PCI-Stroke
(n  79)
Matched Control
Subjects
(n  158) p Value
Age, yrs 74.9 10.0 74.6 9.3 0.78
Male 39 (49) 85 (54) 0.48
Body mass index, kg/m2 28.5 5.1 28.0 5.3 0.53
Unstable angina 40 (51) 70 (44) 0.36
MI within 7 days prior 46 (59) 92 (59) 1.00
History of MI, 7 days 19 (24) 32 (21) 0.51
Pre-procedural shock 9 (11) 19 (12) 0.89
CHF status 0.90
Never 55 (76) 115 (78)
Previous 4 (6) 8 (5)
Current 13 (18) 25 (17)
History of cholesterol 240, mg/dl 56 (80) 99 (68) 0.035
Peripheral vascular disease 15 (19) 36 (24) 0.38
History of CVA or TIA 26 (35) 56 (36) 0.95
Diabetes 24 (31) 57 (36) 0.49
Hypertension 65 (84) 123 (81) 0.47
Moderate-to-severe renal disease 6 (8) 19 (12) 0.28
Current/former smoker 0.90
Never 55 (76) 115 (78)
Former 4 (6) 8 (5)
Current 13 (18) 25 (17)
Prior PTCA 16 (20) 38 (24) 0.51
Prior CABG 14 (18) 34 (22) 0.63
Tumor/lymphoma/leukemia 10 (13) 18 (12) 0.83
Metastatic cancer 1 (1) 3 (2) 0.72
EF 40% 13 (16) 25 (16) 0.90
History of atrial ﬁbrillation 8 (10) 14 (10) 0.82
Values are mean SD or n (%).
CABG  coronary artery bypass graft; PTCA  percutaneous transluminal coronary angio-
plasty; other abbreviations as in Table 1.(7-F) were used in 66% of PCI-stroke patients but only41% of control subjects (Fig. 1). Among PCI procedures
using smaller caliber guides, 6-F was used significantly more
often than 5-F in PCI-stroke procedures than in procedures
for matched controls (p  0.001). Notably there were no
ischemic strokes at all in patients who underwent PCI with
5-F guides.
Retrospective angiographic and procedural review was
performed for all PCI-stroke procedures to determine which
could have been performed with smaller caliber guide
catheters without compromising procedural strategy or dif-
ficulty. Conservatively, it was found that 18 of 30 (60%) of
Table 3. Pre-PCI Medications
PCI-Stroke
(n  79)
Matched Control
Subjects
(n  158) p Value
Heparin 64 (81) 118 (75) 0.25
Thrombolytic 8 (10) 6 (4) 0.06
Antiarrhythmic 11 (14) 19 (12) 0.69
ACE inhibitor 24 (30) 67 (42) 0.07
Aspirin 71 (90) 137 (87) 0.47
Thienopyridine 16 (20) 23 (15) 0.26
Beta-blocker 56 (73) 107 (68) 0.50
Calcium-channel blocker 18 (23) 36 (23) 1.00
Cardiac glycoside 6 (8) 15 (9) 0.64
Diuretic 35 (45) 58 (37) 0.26
Lipid-lowering 21 (28) 49 (31) 0.60
Values are n (%).
ACE  angiotensin-converting enzyme; PCI-stroke  ischemic stroke or transient ischemic
attack related to percutaneous coronary intervention.
Table 4. Angiographic Characteristics
PCI-Stroke
(n  79)
Matched Control
Subjects
(n  158) p Value
No. of diseased vessels (70/50) 1.00
1 17 (21) 35 (23)
2 31 (37) 56 (37)
3 32 (40) 58 (39)
Thrombus in any lesion 38 (54) 68 (47) 0.50
No. of lesions 0.30
1 42 (53) 97 (62)
2 27 (34) 39 (25)
3 8 (10) 15 (10)
4 1 (1) 2 (1)
Urgency of PCI 0.32
Elective 19 (24) 41 (26)
Urgent 30 (38) 70 (44)
Emergency 30 (38) 47 (30)
Vein graft intervention 8 (10) 15 (9) 0.88
Procedural success 56 (71) 132 (85) 0.017
Values are n (%).
PCI percutaneous coronary intervention; PCI-stroke ischemic stroke or transient ischemicattack related to percutaneous coronary intervention.
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2048-F procedures could have been performed as a 6-F proce-
dure without affecting upstream stent strategy, procedural
difficulty, or anticipated strategy in case of failure. Those
procedures that were nonmodifiable (n  12) required 8-F
guides for support due to aortic and coronary anatomy (n 
6), large burr rotational atherectomy (n  4), simultaneous
kissing stents or crush stenting approaches (n  3), and
because of an elevated risk of conversion to a 2-stent
strategy (n  4). Of the 6-F procedures, 16 of 30 (53%)
could be performed with 5-F catheters in the current era.
The remaining, nonmodifiable procedures required 6-F
guides for support (n 10), rotational atherectomy (n 2),
pfront simultaneous balloon approaches (n  4), and
nticipated risk of requiring a simultaneous balloon ap-
Table 5. Procedural Characteristics
PCI-Stroke
(n  79)
Matched Control
Subjects
(n  158) p Value
LV angiogram 16 (20) 29 (19) 0.76
Aortic angiogram 1 (1) 3 (2) 0.72
Thrombectomy 6 (8) 6 (4) 0.19
Rotational atherectomy 8 (10) 5 (3) 0.029
Fluoroscopy time, min 23 (18, 39) 20 (13, 30) 0.14
Contrast volume, cc 250 (160, 350) 218 (150, 275) 0.006
Sheath size, F 7 (6, 8) 6 (6, 8) 0.001
No. of catheters 3 (3, 4) 3 (2, 3) 0.001
Guide caliber 0.001
5-F 0 (0) 19 (12)
6-F 27 (34) 72 (46)
7-F 14 (18) 16 (10)
8-F 38 (48) 49 (31)
No. of catheters 0.001
1 4 (5) 20 (13)
2 4 (5) 37 (24)
3 47 (59) 63 (40)
4 8 (10) 24 (15)
5 16 (20) 12 (8)
Total no. stents placed 1.4 1.2 1.2 1.1 0.35
No. of segments treated 1.7 0.8 1.5 0.8 0.14
Total no. vessels treated 0.68
1 66 (77) 126 (80)
2 17 (22) 30 (19)
3 1 (1) 2 (1)
Prophylactic IABP 4 (5) 8 (5) 1.00
Urgent IABP 9 (11) 4 (3) 0.005
LV assist device 1 (1) 1 (1) 0.63
GP IIb/IIIa inhibitor use 41 (52) 70 (44) 0.22
Peak ACT, s 313 (286, 341) 298 (267, 349) 0.80
Values are n (%), median (Q1, Q3), or mean SD.
ACT activated clotting time; IABP intra-aortic balloon pump; GP glycoprotein; LV left
ventricular; PCI-stroke  ischemic stroke or transient ischemic attack related to percutaneous
coronary intervention.roach (n  5).Procedural variables that did not differ between stroke
nd control patients included total fluoroscopy time, the use
f left ventricle and aortic angiography, use of thrombec-
omy, glycoprotein IIb/IIIa inhibitors, performance of mul-
ivessel intervention (which was included in the matching),
rophylactic intra-aortic balloon pump use (likely because of
atching for cardiogenic shock), and peak activated clotting
ime during the procedure. Evaluation of the entire PCI
opulation revealed no statistically significant difference in
he rate of ischemic stroke occurring in procedures that
mployed a radial versus femoral approach over this period
0.4% vs. 0.4%, p  0.78).
iscussion
In this study, by matching affected and unaffected individuals
at similar risk of an event, we have identified several procedural
factors associated with PCI-related ischemic stroke. Ischemic
stroke occurred after PCI procedures during which large
diameter guide calibers, increasing numbers of catheter ex-
changes, and rotational atherectomy devices were used, in addi-
tion to those cases necessitating greater volumes of contrast.
Despite an increase in applicability and procedural com-
plexity, the risks of most major PCI complications, includ-
ing death, continue to decline (3,4). The rate of PCI-related
stroke, however, has remained static over the last 20 years
with ongoing catastrophic short- and long-term outcomes
(1,6–8). Whereas previous studies have indicated that the
risk of PCI-stroke increases with age and demographic
parameters, these are not modifiable. Accordingly, it is impor-
tant to establish whether there are modifiable, non-patient-
dependent predictors of stroke. Recognition of such associa-
tions might allow for the adjustment of procedural techniques
Figure 1. Guide Catheter Caliber in Procedures Resulting in
PCI-Stroke Versus Matched Control Subjects
PCI-stroke  ischemic stroke or transient ischemic attack related to
percutaneous coronary intervention.
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205when performing PCI, particularly in those patients at greatest
risk of a periprocedural cerebrovascular event.
Consistent with previous studies (1,6–8), the patient-
dependent (thus nonmodifiable) predictors of ischemic
stroke identified in the present study included age, sex,
multivessel coronary disease, coexisting peripheral arterial
disease, and history of prior stroke or TIA. All of these
could be considered as surrogate markers of atherosclerotic
plaque burden and complex aortic anatomy. The current
study does highlight a subset of patients at particularly high
risk. Women over 80 years of age with a prior history of
stroke or TIA were found to have a 3% risk of PCI-ischemic
stroke. This is similar in magnitude to the stroke risk
associated with transcutaneous aortic valve implantation
(15). A number of prophylactic emboli deflection and filter
devices designed to reduce transcutaneous aortic valve im-
plantation embolic stroke risk are under investigation.
Whether high-risk PCI subsets could be similarly targeted
with such devices is worthy of strong consideration.
It remains speculative that the relationship between
procedural factors and the occurrence of ischemic stroke is
causative. As the presence of atheromatous plaque in the
aortic arch poses a risk of spontaneous embolism and is an
independent risk factor for recurrent stroke (16–19), it is
thus certainly possible that procedural associations identi-
fied, including number of catheter exchanges and use of
larger caliber guides, are surrogate markers of aortic disease
and plaque burden. That said, these procedural factors also
directly increase the chance of dislodging atherosclerotic
debris from the aorta by physical abrasion, thereby inducing
embolization. Earlier studies have suggested that large (8-F
and 9-F) lumen guiding catheters displace debris from the
aorta more than one-half of the time during PCI, and that
the likelihood of displacing debris is greater in larger versus
smaller caliber catheters (14,20). Consistent with this no-
tion, in the present study, multiple catheter exchanges and
greater guide caliber were both independently associated
with increased risk of ischemic stroke.
A key issue is to what extent such procedural factors may
be modifiable. Regarding guide catheter caliber, the current
study determined that more than one-half of 8-F proce-
dures could have been performed as 6-F procedures without
affecting strategy or difficulty, suggesting a significant de-
gree of modifiability. Noting that there were no strokes at all
with 5-F procedures, it was also found that more than
one-half of the 6-F procedures were straightforward enough
for a 5-F approach.
Acknowledging modifiable procedural factors, altering
current practice necessitates meticulous procedural planning
when performing complex PCI in high-risk patients. Start-
ing with the correct guide for PCI and considering using a
single diagnostic or guiding catheter designed to intubate
both coronaries may serve to reduce the number of catheter
exchanges. Planning of bifurcation techniques, use of s“mother–child” techniques for support and acknowledging
5-F PCI feasibility can all help to further limit guide size.
Consideration could be given to imaging aortic arch plaque
distribution in high-risk subsets, which might influence
choice of access site. Finally, modifying the technique of
catheter exchange warrants thought and investigation as a
potential target in reducing trauma to the atheromatous
aorta.
The procedural variables that did not differ between
stroke patients and nonstroke control subjects were also of
interest in this analysis. Crossing the aortic valve particularly
in elderly patients has long been assumed to be associated
with an increased risk for stroke. However, we found that
left ventricular (LV) angiography was undertaken no more
frequently in the stroke group than in the control group. In
prior transcranial Doppler studies, most microembolic sig-
nals were detected during contrast injection and LV angiog-
raphy (21). The correlation between Doppler signals and
clinical events, however, is poor, leading to the conclusion
that most emboli are gaseous and harmless. The present
study suggests that avoiding LV angiography does not affect
ischemic stroke risk. We found no difference in periproce-
dural usage of aspirin, thienopyridines, glycoprotein IIb/IIIa
agents, heparin, and mean procedural activated clotting time
in PCI-stroke patients compared with control subjects. In
contrast, a recent National Cardiovascular Data Registry
(NCDR) study identified significant differences in anti-
platelet usage between groups (8). These seemingly discrep-
ant findings may be due to the inclusion of hemorrhagic
strokes as part of the latter study.
We have previously shown that the incidence of PCI-
stroke has not changed over a 16-year period (1). It seems
likely that refinement in technique or devices that might be
expected to reduce the incidence has been offset by a
corresponding increase in the risk profile of patients under-
going PCI. Risk factors for PCI-stroke that have been
previously identified have been mostly patient-related and
unavoidable. The present study identifies technical factors
that are associated with the occurrence of ischemic/embolic
stroke. A number of these technical factors are associated
with an increased propensity to displace atheroma from the
aortic wall. Whereas it remains to be determined whether
modification of procedural techniques affects ischemic
stroke risk in future, it seems reasonable to employ tech-
niques, such as the use of small caliber guides and minimal
catheter exchanges, particularly when undertaking PCI in
patients at highest risk for an event, such as elderly females
with a prior history of stroke.
Study limitations. The present study is a retrospective anal-
sis from a single institution, which might limit its broad
pplication. Our small sample size precluded the ability to
nvestigate associations between stroke and procedural vari-
bles in a multivariable model. Due to the small number of
troke patients, a propensity score matching approach was
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206used, rather than adjusting or matching for variables sepa-
rately. National Institutes of Health Stroke Scale assessment
was not available for a significant number of patients, such
that stratification of outcome by degree of impairment was
not possible. Even though records were scrutinized to
ensure that all events included were appropriate, it is
possible that a number of strokes went unrecognized (non-
specific symptoms, brief duration, occurrence of sudden
death without post-mortem evaluation), thereby underesti-
mating the true incidence.
Conclusions
Ischemic stroke related to PCI is associated with potentially
modifiable technical parameters. Careful procedural plan-
ning should thus be undertaken in an attempt to reduce the
risk of PCI-stroke, particularly in patients at increased risk.
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